Intuitive logo

Intuitive

Stock
Stock
Ticker: ISRG
ISRG

Price

Price

CHART BY

Frequently asked questions

The market capitalization of Intuitive is $129.68B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Intuitive is 42.07. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Intuitive's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $8.725. EPS indicates the company's profitability on a per-share basis.
Currently, 34 analysts cover Intuitive's stock, with a consensus target price of $479.86. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Intuitive reported a revenue of $11.03B.
Intuitive's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $4.19B. EBITDA measures the company's overall financial performance.
Intuitive has a free cash flow of $3.22B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Intuitive employs approximately 17,021 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Intuitive is 350.75M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$129.68B
EPS (TTM) 
$8.725
Free Float 
350.75M
P/E ratio (TTM) 
42.07
Revenue (TTM) 
$11.03B
EBITDA (TTM) 
$4.19B
Free Cashflow (TTM) 
$3.22B

Pricing

1D span
$366.87$372.84
52W span
$328.57$603.70

Analyst Ratings

The price target is $479.86 and the stock is covered by 34 analysts.

Buy

24

Hold

9

Sell

1

Information

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Employees
17,021
Industries
Medical Specialties
Sector
Health Care

Identifier

Primary Ticker
ISRG

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation